All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
The Epstein–Barr virus (EBV), also called human herpesvirus 4 (HHV-4), is a virus of the herpes family,
and is one of the most common viruses in humans.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-ZP8722 | Anti-EBV (E1D1) h(CD28-CD3ζ) CAR, pCDCAR1 | EBV gH/gL | E1D1 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP8723 | Anti-EBV (E1D1) h(4-1BB-CD3ζ) CAR, pCDCAR1 | EBV gH/gL | E1D1 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP8724 | Anti-EBV (AMMO5) h(CD28-CD3ζ) CAR, pCDCAR1 | EBV gB | AMMO5 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP8725 | Anti-EBV (AMMO5) h(4-1BB-CD3ζ) CAR, pCDCAR1 | EBV gB | AMMO5 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP8726 | Anti-EBV (AMMO2) h(CD28-CD3ζ) CAR, pCDCAR1 | EBV gB | AMMO2 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP8727 | Anti-EBV (AMMO2) h(4-1BB-CD3ζ) CAR, pCDCAR1 | EBV gB | AMMO2 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP8728 | Anti-EBV (AMMO1) h(CD28-CD3ζ) CAR, pCDCAR1 | EBV gB | AMMO1 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP8729 | Anti-EBV (AMMO1) h(4-1BB-CD3ζ) CAR, pCDCAR1 | EBV gB | AMMO1 | Rabbit | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION